ArticleAntimicrobial agents and chemotherapy2013

Bioengineered lysozyme reduces bacterial burden and inflammation in a murine model of mucoid Pseudomonas aeruginosa lung infection.

Charlotte C Teneback et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.